MALDI mass spectrometry as a tool for characterizing glycosaminoglycan oligosaccharides and their interaction with proteinsSTURIALE, Luisa; NAGGI, Annamaria; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 465-472, issn 0094-6176Article

Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human cathepsin GSISSI, Claudia; LUCATELLO, Lorena; NAGGI, Annamaria et al.Biochemical pharmacology. 2005, Vol 71, Num 3, pp 287-293, issn 0006-2952, 7 p.Article

Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycansCASU, Benito; NAGGI, Annamaria; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 335-342, issn 0094-6176Article

Heparanase : Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateVLODAVSKY, Israel; ILAN, Neta; NAGGI, Annamaria et al.Current pharmaceutical design. 2007, Vol 13, Num 20, pp 2057-2073, issn 1381-6128, 17 p.Article

Effects of sulfation on antithrombin-thrombin/factor Xa interactions in semisynthetic low molecular weight heparinsSISSI, Claudia; NAGGI, Annamaria; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 483-487, issn 0094-6176Article

Low molecular weight heparins : Structural differentiation by bidimensional nuclear magnetic resonance spectroscopyGUERRINI, Marco; GUGLIERI, Sara; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 478-487, issn 0094-6176, 10 p.Conference Paper

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivativesSCHLESINGER, Martin; SCHMITZ, Patrick; ZEISIG, Reiner et al.Thrombosis research. 2012, Vol 129, Num 5, pp 603-610, issn 0049-3848, 8 p.Article

Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patternsSISSI, Claudia; NAGGI, Annamaria; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2003, Vol 29, Num 6, pp 661-670, issn 0094-6176, 10 p.Article

Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparinsSISSI, Claudia; LUCATELLO, Lorena; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 355-359, issn 0094-6176Article

The Tainted Heparin Story: An UpdateGUERRINI, Marco; SHRIVER, Zachary; BISIO, Antonella et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 907-911, issn 0340-6245, 5 p.Conference Paper

Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharideNAGGI, Annamaria; TORRI, Giangiacomo; CASU, Benito et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 437-443, issn 0094-6176Article

Structure of a heteroxylan of gum exudate of the palm Scheelea phalerata (uricuri)SIMAS, Fernanda F; GORIN, Philip A. J; GUERRINI, Marco et al.Phytochemistry. 2004, Vol 65, Num 16, pp 2347-2355, issn 0031-9422, 9 p.Article

Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharidePOGGI, Andreina; ROSSI, Cosmo; CASELLA, Nicola et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 383-391, issn 0094-6176Article

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 AxisRITCHIE, Joseph P; RAMANI, Vishnu C; ZUNINO, Franco et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1382-1393, issn 1078-0432, 12 p.Article

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsGUERRINI, Marco; BECCATI, Daniela; AL-HAKIM, Ali et al.Nature biotechnology (Print). 2008, Vol 26, Num 6, pp 669-675, issn 1087-0156, 7 p.Article

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYANG YANG; MACLEOD, Veronica; VLODAVSKY, Israel et al.Blood. 2007, Vol 110, Num 6, pp 2041-2048, issn 0006-4971, 8 p.Article

Structural features of low-molecular-weight heparins affecting their affinity to antithrombinBISIO, Antonella; VECCHIETTI, Davide; CITTERIO, Laura et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 865-873, issn 0340-6245, 9 p.Conference Paper

High-performance liquid chromatographic/ mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanaseBISIO, Antonella; MANTEGAZZA, Alessandra; URSO, Elena et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 488-495, issn 0094-6176, 8 p.Conference Paper

O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasisBORGENSTRÖM, Marjut; WÄRRI, Anni; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 547-556, issn 0094-6176, 10 p.Conference Paper

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solutionHRICOVINI, Milos; GUERRINI, Marco; BISIO, Antonella et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 325-334, issn 0094-6176Article

Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeHARENBERG, Job; CASU, Benito; GUERRINI, Marco et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 343-354, issn 0094-6176Article

Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4SCHMITZ, Patrick; GERBER, Ursula; SCHÜTZE, Norbert et al.Thrombosis and haemostasis. 2013, Vol 110, Num 5, pp 1046-1054, issn 0340-6245, 9 p.Article

Reversed-phase ion-pair ultra-high-performance-liquid chromatography―mass spectrometry for fingerprinting low-molecular-weight heparinsLANGESLAY, Derek J; URSO, Elena; GARDINI, Cristina et al.Journal of chromatography. 2013, Vol 1292, pp 201-210, issn 0021-9673, 10 p.Article

Undersulfated and glycol-split heparins endowed with antiangiogenic activityCASU, Benito; GUERRINI, Marco; PENCO, Sergio et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 4, pp 838-848, issn 0022-2623, 11 p.Article